18 June 2021
Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics Holdings Limited (02171.HK)’s mainboard listing on the Stock Exchange of Hong Kong.
Advising firms
Deal team
17 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Emsley Lead | Herbert Smith Freehills | Partner | Not stated | Hong Kong |
| Stanley Xie Lead | Herbert Smith Freehills | Partner | Not stated | Not stated |
| Lucy Yao Lead | Herbert Smith Freehills | Other | Not stated | Not stated |
| Siddhartha Sivaramakrishnan | Herbert Smith Freehills | Partner | Not stated | Singapore |
| George Wu | Herbert Smith Freehills | Of counsel | Not stated | Hong Kong |
| Maisie Ko | Herbert Smith Freehills | Senior associate | Not stated | Hong Kong |
| Echo Shen | Herbert Smith Freehills | Associate | Not stated | Hong Kong |
| Angela Yuen | Herbert Smith Freehills | Associate | Not stated | Hong Kong |
| Hilary Chong | Herbert Smith Freehills | Other | Not stated | Hong Kong |
| Sean Ji | Herbert Smith Freehills | Associate | Not stated | Not stated |
| Sunny Li | Herbert Smith Freehills | Other | Not stated | Sydney |
| Jasmin Tsang | Herbert Smith Freehills | Trainee | Not stated | Hong Kong |
| Alisha Chan | Herbert Smith Freehills | Other | Not stated | Not stated |
| Jessica Sun | Herbert Smith Freehills | Other | Not stated | Not stated |
| Helen Liang | Herbert Smith Freehills | Other | Not stated | Not stated |
| Selina Wang | Herbert Smith Freehills | Other | Not stated | Not stated |
| Shawna Peng | Herbert Smith Freehills | Other | Not stated | Not stated |
Stated terms
- Stated value
- USD 400m (approximately US$400 million)
- What the figure measures
- Issue size
- Client
- Goldman Sachs and UBSSponsor
- Counterparties
- CARsgen Therapeutics Holdings Limited (Issuer)